TRIN Pharma starts phase I clinical trial of TRIN 2755 in solid tumors
11-Nov-2009 -
TRIN Pharma GmbH announced that BfArM, the German regulatory authority, has approved the start of a Phase I clinical trial of TRIN 2755 in solid tumors. The trial will be conducted at two clinical sites in Germany, Westdeutsches Tumorzentrum in Essen and Tumor Biology Center in Freiburg.
TRIN ...
cancer therapy
chemistry
clinical trials
+5